MJ MedTech a California-based wholly-owned subsidiary of Wuhan General Group aims to offer botanical-based medicine to the forefront by deploying medical grade CBD and other plant-based products to help alleviate everyday illness.
MJ MedTech owns two divisions, Dr. AnnaRx, and M2BIO, where each has its own mission:
Dr. AnnaRX is developing and commercializing a range of medical grade full spectrum CBD-based products, distributed under the brand name Dr. AnnaRx in pharmacies with the partnership of local cannabis growers as well as a joint venture with a nutraceuticals research laboratory, BIODELTA.
M2BIO is currently working on the potential benefits of Psilocybin (magic mushroom) supported by the medical and scientific community. More details will be available shortly.